News on clinical chemistry systems and applications.
Since the FDA issued its safety communication in 2017, some lab test developers have mitigated the biotin interference of their assays, but others have not.
Siemens Healthineers will use the technology, which Quanterix acquired as part of its buy of UmanDiagnostics, to develop blood-based Nf-L clinical tests.
The firm said it is tackling challenges in its Diagnostics business, which had 2 percent growth year over year on a comparable basis in its fiscal fourth quarter.
The study reflects the importance of including multiple biomarkers for diagnostic and treatment decisions associated with pneumonia, IVD industry experts said.
The Australian Red Cross Blood Service will use the Alinity s System to process its blood tests and improve lab automation.
